Using a dye to guide precise lung surgery
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have lung cancer (stage I or II) or a lung nodule that is suspected to be cancer.
- Your planned surgery is to remove only the part of the lung containing the nodule, or you cannot have larger surgery due to heart or lung problems.
- You are 18 years or older.
- Your kidney and liver function must be within acceptable limits (checked by blood tests).
- You must not be allergic to indocyanine green dye or iodine, and must not have an overactive thyroid.
- You must not be pregnant or breastfeeding, and must be legally capable of consenting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to plan radiation therapy for lung cancer by using a special imaging technique (functional lung imaging) to see which parts of your lungs work best. The goal is to reduce damage to healthy lung tissue while still targeting the cancer.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This trial tests a special imaging drug (IRDye800CW-nimotuzumab) that may help surgeons better see lung cancer tissue during planned lung surgery. Phase 1/2 looks mainly at safety and how well the imaging works to guide the operation.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
This trial tests a dye called abenacianine (VGT-309) that may help surgeons see cancer more clearly during lung surgery. It looks at whether the dye is safe and effective for identifying cancer in people having surgery to remove a lung lesion or mass.
Hear when a new Pulmonary Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.